JP2024539141A5 - - Google Patents

Info

Publication number
JP2024539141A5
JP2024539141A5 JP2024523627A JP2024523627A JP2024539141A5 JP 2024539141 A5 JP2024539141 A5 JP 2024539141A5 JP 2024523627 A JP2024523627 A JP 2024523627A JP 2024523627 A JP2024523627 A JP 2024523627A JP 2024539141 A5 JP2024539141 A5 JP 2024539141A5
Authority
JP
Japan
Prior art keywords
antibody
seq
muscular dystrophy
binding
acid sequence
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024523627A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024539141A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2022/078510 external-priority patent/WO2023070087A1/en
Publication of JP2024539141A publication Critical patent/JP2024539141A/ja
Publication of JP2024539141A5 publication Critical patent/JP2024539141A5/ja
Pending legal-status Critical Current

Links

JP2024523627A 2021-10-21 2022-10-21 筋ジストロフィーを治療するための組成物及び方法 Pending JP2024539141A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202163270352P 2021-10-21 2021-10-21
US63/270,352 2021-10-21
PCT/US2022/078510 WO2023070087A1 (en) 2021-10-21 2022-10-21 Compositions and methods for treating muscular dystrophy

Publications (2)

Publication Number Publication Date
JP2024539141A JP2024539141A (ja) 2024-10-28
JP2024539141A5 true JP2024539141A5 (cg-RX-API-DMAC7.html) 2025-10-29

Family

ID=86059727

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024523627A Pending JP2024539141A (ja) 2021-10-21 2022-10-21 筋ジストロフィーを治療するための組成物及び方法

Country Status (5)

Country Link
US (1) US20250230225A1 (cg-RX-API-DMAC7.html)
EP (1) EP4419144A4 (cg-RX-API-DMAC7.html)
JP (1) JP2024539141A (cg-RX-API-DMAC7.html)
CA (1) CA3235802A1 (cg-RX-API-DMAC7.html)
WO (1) WO2023070087A1 (cg-RX-API-DMAC7.html)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN117174164B (zh) * 2023-10-30 2024-02-13 晨伫(杭州)生物科技有限责任公司 基于预测蛋白质-小分子结合姿势筛选先导化合物的方法
EP4670793A1 (en) * 2024-06-24 2025-12-31 Montis Biosciences BV C1Q ANTIGEN BINDING MOLECULES

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK3019240T3 (da) * 2013-07-09 2024-06-03 Annexon Inc Anti-komplementfaktor C1Q antistoffer og anvendelser deraf

Similar Documents

Publication Publication Date Title
JP7579227B2 (ja) 瘻孔を伴うクローン病の治療用ベドリズマブ
JP2021501134A5 (cg-RX-API-DMAC7.html)
JP2018512379A5 (cg-RX-API-DMAC7.html)
CN116239698A (zh) 双功能融合蛋白及其医药用途
JP2024539141A5 (cg-RX-API-DMAC7.html)
JP2021191267A5 (cg-RX-API-DMAC7.html)
JP7471224B2 (ja) Ｈ因子増強抗体及びその使用
JP2014509510A5 (cg-RX-API-DMAC7.html)
JP2017534577A5 (cg-RX-API-DMAC7.html)
CN110799543A (zh) 肝细胞癌的免疫治疗
JP2024541680A5 (cg-RX-API-DMAC7.html)
JP2019513726A5 (cg-RX-API-DMAC7.html)
JP2023540526A5 (cg-RX-API-DMAC7.html)
JP2021511387A5 (cg-RX-API-DMAC7.html)
JP2024024114A5 (cg-RX-API-DMAC7.html)
JP2022512863A5 (cg-RX-API-DMAC7.html)
JPWO2020059847A5 (cg-RX-API-DMAC7.html)
JP2024532886A5 (cg-RX-API-DMAC7.html)
JP2022516071A5 (cg-RX-API-DMAC7.html)
JP7377185B2 (ja) 抗ヒトｔｌｒ７抗体
JP2022553851A5 (cg-RX-API-DMAC7.html)
JP2024503784A5 (cg-RX-API-DMAC7.html)
JP2023509373A5 (cg-RX-API-DMAC7.html)
CN121399158A (zh) 用于治疗多发性骨髓瘤的方法
JPWO2022044573A5 (cg-RX-API-DMAC7.html)